Naloxone Market Competitive Insights to 2026: Mylan N.V., Novartis AG, Indivior Plc., ADAPT Pharma, Inc., Amphastar Pharmaceuticals, Inc., INSYS Therapeutics, Inc., Mundipharma International Limited, Kaleo, Inc., and Kern Pharma, S.L.

There are several brands and key players that are driving the Naloxone Market and in turn changing the face of Naloxone industry. This report consists of several Company profiles of the key players which give an idea about what actual markets trends are as well as letting you know about all the recent product launches, their researches, joint ventures, merges, and accusations are by them, so that you stay ahead of the curve in this competitive Naloxone Market.

Download PDF Brochure of This Business Research Report : www.coherentmarketinsights.com/insight/request-pdf/1804

Key Developments in the Market:

•In 2016, Therapeutic Goods Administration (TGA) placed naloxone on Schedule 3 when used for the treatment of opioid overdose, thus allowing the over-the-counter (OTC) purchase of naloxone in Australia.

•In Europe, many countries allow take-home naloxone due to high rate of opioid overdose in this region. Currently, take-home naloxone programs exists in seven European countries— Denmark, Estonia, Germany, Italy, Norway, Spain, and the U.K. (EMCDDA, 2015c).

Market Key Competitors:

•Mylan N.V.
•Novartis AG
•Indivior Plc.
•ADAPT Pharma Inc.
•Amphastar Pharmaceuticals Inc.
•INSYS Therapeutics, Inc.
•Mundipharma International Limited
•Kaleo, Inc.
•Kern Pharma S.L.

Competitive Analysis:

The global Naloxone market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Naloxone market for global, Europe, North America, Asia Pacific and South America

Table Of Contents:

• Introduction.
• Research Methodologies.
• Premium Insights
• Executive Summary
• Market Trends.
• Market Segmentation

• Naloxone Market -By Product Type
• Naloxone Market -By Application
• Naloxone Market -By Type
• Naloxone Market -By Region

• Market Key Company Analysis By:
o Business overview
o Naloxone Sales & Forecast
o Recent Developments / Strategy

• Market Driving Factors
• Market Challenges
• Market Opportunist
• Related Reports

Drivers and Restraints:

Increasing launches and approval of new naloxone products in the market is expected to drive the global naloxone market growth over the forecast period. In October, 2016 Health Canada approved Narcan Nasal Spray 4 mg for non-prescription, community use in Canada

Rising prevalence of opioid overdose in key regions such as North America, and Europe is expected to drive demand for naloxone products and drive the naloxone market growth in the near future. For instance, according to the data published by European Monitoring Center for Drugs and Drug Addiction (EMCDDA), in 2016, around 150,943 high-risk opioid users were reported in Germany and around 330,445 were reported in the U.K.

Furthermore, initiatives by various government and private organizations to increase access of naloxone product among the population is also expected to drive market growth. For instance, in 2015, Kaleo, Inc. partnered with the Clinton Foundation and provided bulk discounts on its EVZIO to various college universities and public safety organizations.

Request for Customization of Research Report: https://www.coherentmarketinsights.com/insight/request-customization/1804

Detailed Segmentation:

• Global Naloxone Market, By Strength:
0.4 mg/ml
1mg/ml
0.4mg/0.4ml
4mg/0.1ml

• Global Naloxone Market, By Drug Type:
Intranasal
Intramuscular/Subcutaneous
Intravenous

• Global Naloxone Market, By Distribution Channel:
Hospitals
Clinics
Retail Pharmacies
Online Pharmacies
Others

• Global Naloxone Market, By Geography:
North America
Europe
Asia Pacific
Latin America
Middle East
Africa

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.